Abstract:Objective To investigate the sodium iodide symporter (NIS) gene expression during different iodine intakes and its function in thyroid autoregulation. Methods BabL/c mice were randomly divided into five groups according to their different iodine intake levels : low iodine (LI), normal iodine (NI), five-fold iodine (5HI) ,ten-fold iodine (10 HI) and fifty-fold iodine (50 HI). After three months and six months administration, they were sacrificed and thyroids were excised. The mRNA and protein expression level were determined by real time quantitative PCR and immunohistochemistry respectively. Iodine content in thyroid tissue was measured with spectrophotometry and thyroid hormone level was measured with radioimmunoassay. Results Compared with NI group, NIS mRNA and protein expression was greatly increased in LI groups. Immunohistochemistry analysis indicated that NIS was mostly located at the basolateral membrane of thyrocyte,suggesting the improved activity in transporting iodine. But when faced with long-term and severe iodine deficiency, the iodine content in thyroid was finally decreased ,and hormone level lowered. On the other hand, in HI groups NIS mRNA and protein expression was greatly down-regulated. There was a tendency of decreasing NIS gene expression level with increasing doses of iodine intakes. In addition, NIS protein was found mainly in intracellular vesicles, rather than at the cell membrane,suggesting the loss of its activity. The iodine content in thyroid tissue was only slightly increased and was not consistent with the iodine intake levels. Conclusion These findings indicate that NIS may be. regulated at transcription, translation and post-translation levels. This phenomenon constitutes a highly specialized intrinsic autoregulatory system that protects thyroid from high doses of iodine, but at the same time ensures adequate iodine uptake for hormone biosynthesis. NIS plays a critical role in thyroid autoregulation mechanism.

Sodium Iodide Symporter and Thyroid Disease

[Iodine, sodium-iodine symporter and thyroid diseases]

Sodium Iodide Symporter Gene Expression in Thyroid of Mice with Different Iodine Intakes

Sodium-iodide symporter and its related solute carriers in thyroid cancer

Basolateral Sorting of the Sodium/Iodide Symporter Is Mediated by Adaptor Protein 1 Clathrin Adaptor Complexes

Gene Expression of Sodium/Iodine Symporter in Thyroid Tissues

Expression of sodium/iodide symporter(NIS)protein in differentiated benign and malig-nant thyroid diseases

Effects of iodine on the thyroid sodium iodide symporter mRNA expression and thyroid function in rats

Advances of Radioiodine Therapy of Tumor Induced by Sodium Iodide Symporter Gene

Sodium iodide symporter gene-mediated radionuclide therapy of tumors

Progress in Sodium Iodide Symporter for Tumors

Intracellular Iodinated Compounds Affect Sodium Iodide Symporter Expression Through TSH-mediated Signaling Pathways.

Investigation of Value of Na~+/I~- Symporter Expression on Diagnosis of Thyroid Carcinoma and Prediction of ~(131)Ⅰ Therapeutic Effects

The sodium iodide symporter (NIS): novel applications for radionuclide imaging and treatment

Fluoride Exposure Induces Inhibition of Sodium/Iodide Symporter (NIS) Contributing to Impaired Iodine Absorption and Iodine Deficiency: Molecular Mechanisms of Inhibition and Implications for Public Health

Detection of Autoantibodies to Human Sodium Iodide Symporter in Patients with Autoimmune Thyroid Diseases

Expression of sodium iodide symporter mRNA and its clinical significance in differentiated thyroid carcinoma

Relationship of sodium-iodide symporter gene and protein expression in breast tissue with the occurrence of breast disease

Expression and Significance of the Sodium Iodide Symporter Mrna and Thyroperoxidase Mrna in Thyroid Lesions

S-Nitrosylation of NF-κB p65 Inhibits TSH-Induced Na(+)/I(-) Symporter Expression

Effect to Therapy of Sodium-Iodine Symporter Expression by Alpha-Ray Therapeutic Agent via Sodium/Iodine Symporter